Rights and permissions
About this article
Cite this article
KRAS status predicts response to cetuximab in mCRC. Inpharma Wkly. 1641, 7 (2008). https://doi.org/10.2165/00128413-200816410-00018
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816410-00018